Speakers Dr. Erika Cecchin, PharmD, PhD Clinical Pharmacologist –Experimental and Clinical Pharmacology (ECP) Aviano National Cancer Institute (CRO), IRCCS (italy)
“Personalizing Cancer Therapy Through Pharmacogenetics: DPYD, UGT1A1 and beyond”
Dr. Stefania Tommasi Head – Unit of Molecular Diagnostics and Pharmacogenetics Giovanni Paolo II Cancer Institute, Bari (Italy)
“Implementing DPYD and UGT1A1 Testing in Clinical Practice”
This session will highlight the clinical value of pharmacogenetic testing in oncology, focusing on DPYD, UGT1A1 and other emerging biomarkers. Experts will share guidelines, real-world data, and practical experience on how testing can prevent severe toxicities and support safer, more personalized cancer treatment.